Brookstone Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Buy
5,391
+239
+5% +$15.9K ﹤0.01% 1028
2026
Q1
$324K Buy
5,152
+990
+24% +$68.9K ﹤0.01% 1005
2025
Q4
$276K Buy
+4,162
New +$269K ﹤0.01% 1012

Other funds holding DXCM

Brookstone Capital Management's DXCM Position: Q2 2026 in Review

Brookstone Capital Management increased its DexCom (DXCM) stake by 4.6% in Q2 2026, buying an estimated $15.9K and bringing the position to 5,391 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Brookstone Capital Management first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Brookstone Capital Management held 5,391 shares of DexCom worth $363K as of Q2 2026.
  • Brookstone Capital Management bought 239 DexCom shares in Q2 2026, an estimated $15.9K.
  • DexCom made up ﹤0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #1028 holding.
  • Brookstone Capital Management first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.